Company Profile
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data systems for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. In addition, it provides on-schedule delivery services to pharmacies, drugstores, doctors, hospitals, and care homes. The company was founded in 1927 and is headquartered in Bern, Switzerland.
Latest News
Goldman Sachs leads oil and gas M&A advisory by value in H1 2026
Philippines' Marcos says 'perhaps time to revisit nuclear energy'
Camden National Bank Earnings: What To Look For From CAC
Black Book Expands Vendor-Agnostic Healthcare Supply Chain Technology Benchmark to 36 Categories for AHRMM26
Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth
| Sector | Healthcare |
| Industry | Medical Distribution |
| Website | https://www.galenica.com |
| Audit Risk | 2 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 4.36B |
| Trailing P/E | 23.91 |
| Forward P/E | 20.52 |
| Dividend Rate | 2.5 |
| Dividend Yield | 2.88% |
| Trailing Annual Div. Rate | 2.5 |
| Trailing Annual Div. Yield | 2.88% |
| Trailing EPS | 3.66 |
| Forward EPS | 4.26 |
| Book Value | 29.74 |
| Price-to-Book | 2.94 |
| Enterprise-to-Revenue | 1.27 |
| Enterprise-to-EBITDA | 19.62 |
| Ex-Dividend Date | 04/23/2026 |
| Dividend Date | 04/16/2025 |
| Earnings Date | |
| Earnings Call Date |